Precision Biosciences Inc (DTIL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Sales | 0 | 10,838 | 34,204 | 13 | 18 |
| Gross Profit | N/A | 10,838 | 34,204 | 13 | 18 |
| Operating Expenses | 19,161 | 19,913 | 21,696 | 20,680 | 21,895 |
| Operating Income | -19,161 | -9,075 | 12,508 | -20,667 | -21,877 |
| Interest Expense | 300 | 311 | 348 | 362 | 358 |
| Other Income | -13,191 | -9,055 | 7,088 | -743 | -1,285 |
| Pre-tax Income | -32,652 | -18,441 | 19,248 | -21,772 | -23,520 |
| Net Income Continuous | -32,652 | -18,441 | 19,248 | -21,772 | -23,520 |
| Net Income | $-32,652 | $-18,441 | $20,133 | $-21,772 | $-23,520 |
| EPS Basic Total Ops | -1.26 | -0.75 | 2.62 | -1.84 | -2.13 |
| EPS Basic Continuous Ops | -1.26 | -0.75 | 2.55 | -1.84 | -2.13 |
| EPS Diluted Total Ops | -1.26 | -0.75 | 2.62 | -1.84 | -2.13 |
| EPS Diluted Continuous Ops | -1.26 | -0.75 | 2.55 | -1.84 | -2.13 |
| EPS Diluted Before Non-Recurring Items | -0.71 | -0.34 | 0.36 | -1.84 | -2.13 |
| EBITDA(a) | $-18,558 | $-8,435 | $13,186 | $-20,224 | $-21,359 |